|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Current assets | ||||||||||||
| Cash | ||||||||||||
| Cash – restricted | ||||||||||||
| Prepaid expenses | ||||||||||||
| Restricted funds – held in Trust Account | ||||||||||||
| Total current assets | ||||||||||||
| Deferred tax asset | ||||||||||||
| Prepaid insurance | ||||||||||||
| Cash and marketable securities in Trust Account | ||||||||||||
| Prepaid insurance | ||||||||||||
| Marketable securities held in Trust Account | ||||||||||||
| Total Assets | ||||||||||||
| Liabilities and Stockholders’ Deficit | ||||||||||||
| Current liabilities | ||||||||||||
| Accounts payable and accrued expenses | ||||||||||||
| Accrued offering costs | ||||||||||||
| Income taxes payable | ||||||||||||
| Promissory note related party | ||||||||||||
| Deferred tax liability | ||||||||||||
| Excise tax payable | ||||||||||||
| Class A common stock pending redemptions (4,520,384 shares) | ||||||||||||
| Stockholders redemption payable | ||||||||||||
| Promissory note - related party | ||||||||||||
| Related Party | ||||||||||||
| Total promissory note - related party | ||||||||||||
| Promissory note - 2nd amended and restated | ||||||||||||
| Convertible promissory note and forward settlement contract - related party | ||||||||||||
| Total current liabilities | ||||||||||||
| Deferred underwriting fee payable | ||||||||||||
| Deferred underwriting fee payable | ||||||||||||
| Deferred underwriting fee payable | ||||||||||||
| Deferred tax liability | ||||||||||||
| Deferred underwriting fee payable | ||||||||||||
| Total Liabilities | ||||||||||||
| Class A common stock subject to possible redemption, 332,816 and 2,379,616 shares at redemption value at $11.76 and $11.19 per share as of December 31, 2025 and December 31, 2024, respectively | ||||||||||||
| Class A Common Stock | ||||||||||||
| Class A common stock subject to possible redemption | ||||||||||||
| Total class A Common Stock | ||||||||||||
| Total class A common stock subject to possible redemption, 332,816 and 2,379,616 shares at redemption value at $11.76 and $11.19 per share as of December 31, 2025 and December 31, 2024, respectively | ||||||||||||
| Stockholders’ Deficit | ||||||||||||
| Common stock value | ||||||||||||
| Common stock, value | ||||||||||||
| Accumulated deficit | ||||||||||||
| Total Stockholders’ Deficit | ||||||||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
